 |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Thursday, September 2, 2010
|
|
|
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Thursday, September 2, 2010
|
Diabetes |
ONGLYZA01/12/2010 |
Please provide brief info about new medication ONGLYZA. Is it sumilar to any other? How does it work and what advantages (disadvantages) it has.Thanks.
The manufacturer provides information approved by the US Food and Drug Administration at the following web site: http://packageinserts.bms.com/ppi/ppi_onglyza.pdf. The generic (chemical) name is saxagliptin. It is similar to another drug sitagliptin (brand name Januvia). Both act by increasing the amount of insulin produced by the pancreas. Advantages and disadvantages should be considered in the context of all other alternatives with a health care professional familiar with your overall situation.
|
Robert M. Cohen, MD Associate Professor Division of Endocrinology and Metabolism Department of Internal Medicine College of Medicine University of Cincinnati |
|
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|